INAB Logo

IN8bio, Inc. (INAB) 

NASDAQ
Market Cap
$38.78M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
342 of 809
Rank in Industry
208 of 445

Largest Insider Buys in Sector

INAB Stock Price History Chart

INAB Stock Performance

About IN8bio, Inc.

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Insider Activity of IN8bio, Inc.

Over the last 12 months, insiders at IN8bio, Inc. have bought $28,395 and sold $0 worth of IN8bio, Inc. stock.

On average, over the past 5 years, insiders at IN8bio, Inc. have bought $1.44M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Ho William Tai-Wei (President and CEO) — $24,990. Graff Jeremy R. (director) — $2,375. McCall Patrick (Chief Financial Officer) — $1,030.

The last purchase of 2,500 shares for transaction amount of $2,375 was made by Graff Jeremy R. (director) on 2023‑09‑13.

List of Insider Buy and Sell Transactions, IN8bio, Inc.

2023-09-13PurchaseGraff Jeremy R.director
2,500
0.0077%
$0.95$2,375+14.24%
2023-08-25PurchaseMcCall PatrickChief Financial Officer
1,000
0.0032%
$1.03$1,030+2.91%
2023-08-24PurchaseHo William Tai-WeiPresident and CEO
23,800
0.0719%
$1.05$24,990+3.92%
2022-12-12PurchaseKreis Leslie W.director
75,001
0.359%
$2.48$185,912-44.94%
2022-12-12PurchaseFletcher Aaron G.L.director
75,001
0.359%
$2.48$185,912-44.94%
2022-09-28PurchaseKreis Leslie W.
25,000
0.1111%
$2.02$50,535-18.57%
2022-09-28PurchaseFletcher Aaron G.L.
25,000
0.1111%
$2.02$50,535-18.57%
2022-08-26PurchaseCavu Advisors, LLC
31,805
0.1513%
$2.02$64,232-5.10%
2022-08-17PurchaseCavu Advisors, LLC
38,035
0.1712%
$1.93$73,408-5.30%
2022-08-17PurchaseBIOS Advisors GP, LLC
38,035
0.1712%
$1.93$73,408-5.30%
2022-08-16PurchaseTranscend Partners Opportunity Fund LLC
789,473
3.713%
$1.90$1.5M+1.07%
2022-08-16PurchaseHo William Tai-WeiPresident, CEO and CFO
26,315
0.1238%
$1.90$49,999+1.07%
2022-08-16PurchaseCavu Advisors, LLC
206,575
0.9715%
$1.90$392,493+1.07%
2022-08-16PurchaseBIOS Advisors GP, LLC
206,575
0.9715%
$1.90$392,493+1.07%
2022-08-16PurchaseBrandt Peter C.
105,263
0.4951%
$1.90$200,000+1.07%
2022-08-16PurchaseLamb LawrenceEVP and CSO
526
0.0025%
$1.90$999+1.07%
2022-08-16PurchaseRoemer Alan S.
26,315
0.1238%
$1.90$49,999+1.07%
2022-08-16PurchaseGreenwood Luba
526
0.0025%
$1.90$999+1.07%
2022-08-16PurchaseRochlin KateChief Operating Officer
5,263
0.0248%
$1.90$10,000+1.07%
2022-08-16PurchaseMcCall PatrickChief Financial Officer
5,263
0.0248%
$1.90$10,000+1.07%

Insider Historical Profitability

<0.0001%
Ho William Tai-WeiPresident and CEO
2339545
5.4047%
$0.8820+1.07%
McCall PatrickChief Financial Officer
6263
0.0145%
$0.8820+1.07%
Graff Jeremy R.director
2500
0.0058%
$0.8810
Transcend Partners Opportunity Fund LLC
4111958
9.4992%
$0.8810+1.07%
Kreis Leslie W.director
3727597
8.6113%
$0.8820<0.0001%
Fletcher Aaron G.L.director
3727597
8.6113%
$0.8820<0.0001%
Cavu Advisors, LLC
3651528
8.4356%
$0.8830<0.0001%
BIOS Advisors GP, LLC
3612569
8.3456%
$0.8820<0.0001%
FAIRBAIRN EMILY
3322485
7.6754%
$0.8810<0.0001%
Brandt Peter C.
182473
0.4215%
$0.8810+1.07%
Lamb LawrenceEVP and CSO
99730
0.2304%
$0.8810+1.07%
Roemer Alan S.
55989
0.1293%
$0.8810+1.07%
Greenwood Luba
7826
0.0181%
$0.8810+1.07%
Rochlin KateChief Operating Officer
5263
0.0122%
$0.8810+1.07%
Goswami TrishnaChief Medical Officer
2631
0.0061%
$0.8810+1.07%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Aigh Capital Management Llc$3.39M6.522.87M-29.85%-$1.44M2.01
The Vanguard Group$1.68M3.231.42M+241.71%+$1.19M<0.0001
Ensign Peak Advisors Inc$1.32M2.531.12M0%+$0<0.01
683 Capital Management Llc$725,410.001.39614,7540%+$00.08
Sigma Planning Corp$607,794.001.17515,080+289.53%+$451,762.700.02
Alyeska Investment Group L P$526,299.001.01446,016-45.59%-$440,914.18<0.01
Voss Capital LLC$381,705.000.73323,479-5.2%-$20,921.390.03
Geode Capital Management$331,106.000.64280,544+40.68%+$95,748.39<0.0001
Stonegate Investment Group Llc$212,400.000.41180,0000%+$00.01
Rock Creek Group Lp$208,813.000.34151,3140%+$0<0.0001
Renaissance Technologies$141,000.000.27119,155+508.62%+$117,832.71<0.0001
Bridgeway Capital Management$121,896.000.23103,302+31.93%+$29,499.91<0.01
Texas Capital Bank Wealth Management Services Inc$92,776.000.1878,6240%+$00.01
State Street$69,910.000.1359,2460%+$0<0.0001
Northern Trust$57,845.000.1149,0210%+$0<0.0001
Laird Norton Trust Company Llc$49,914.000.142,3000%+$00.01
Two Sigma$49,003.000.0941,528-1.89%-$941.64<0.0001
Overbrook Management Corp$39,832.000.0833,7560%+$00.01
Millennium Management LLC$38,417.000.0732,557New+$38,417.00<0.0001
BlackRock$33,281.000.0628,204-2.15%-$731.61<0.0001
Wela Strategies Inc$21,887.000.0418,548New+$21,887.000.01
TWO SIGMA SECURITIES LLC$20,717.000.0417,557New+$20,717.00<0.0001
Ground Swell Capital Llc$19,300.000.0416,356New+$19,300.000.02
Virtu Financial Llc$17,000.000.0314,044New+$17,000.00<0.01
Charles Schwab$15,464.000.0313,1050%+$0<0.0001
Westside Investment Management Inc$14,160.000.0312,000-17.24%-$2,950.00<0.01
Goldman Sachs$13,702.000.0311,612New+$13,702.00<0.0001
Tower Research Capital$12,851.000.0310,891+78.89%+$5,667.37<0.0001
Vontobel Holding Ltd$11,800.000.0210,0000%+$0<0.0001
Wells Fargo$291.00<0.01247+56.33%+$104.85<0.0001
JPMorgan Chase$81.00<0.0169+102.94%+$41.09<0.0001
Royal Bank of Canada$0<0.0147-82.2%-$0<0.0001